Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
Jacob A. Torres, … , Michal Mrug, Thomas Weimbs
Jacob A. Torres, … , Michal Mrug, Thomas Weimbs
Published July 30, 2019
Citation Information: J Clin Invest. 2019;129(10):4506-4522. https://doi.org/10.1172/JCI128503.
View: Text | PDF | Corrigendum
Research Article Nephrology

Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease

  • Text
  • PDF
Abstract

The rate of disease progression in autosomal-dominant polycystic kidney disease (ADPKD) has high intrafamilial variability, suggesting that environmental factors may play a role. We hypothesized that a prevalent form of renal insult may accelerate cystic progression and investigated tubular crystal deposition. We report that calcium oxalate (CaOx) crystal deposition led to rapid tubule dilation, activation of PKD-associated signaling pathways, and hypertrophy in tubule segments along the affected nephrons. Blocking mTOR signaling blunted this response and inhibited efficient excretion of lodged crystals. This mechanism of “flushing out” crystals by purposefully dilating renal tubules has not to our knowledge been previously recognized. Challenging PKD rat models with CaOx crystal deposition or inducing calcium phosphate deposition by increasing dietary phosphorus intake led to increased cystogenesis and disease progression. In a cohort of patients with ADPKD, lower levels of urinary excretion of citrate, an endogenous inhibitor of calcium crystal formation, were correlated with increased disease severity. These results suggest that PKD progression may be accelerated by commonly occurring renal crystal deposition that could be therapeutically controlled by relatively simple measures.

Authors

Jacob A. Torres, Mina Rezaei, Caroline Broderick, Louis Lin, Xiaofang Wang, Bernd Hoppe, Benjamin D. Cowley Jr., Vincenzo Savica, Vicente E. Torres, Saeed Khan, Ross P. Holmes, Michal Mrug, Thomas Weimbs

×

Figure 3

Acute CaOx crystal deposition leads to rapid tubule dilation, activation of PKD-associated signaling pathways, and hypertrophy in WT rats.

Options: View larger image (or click on image) Download as PowerPoint
Acute CaOx crystal deposition leads to rapid tubule dilation, activation...
(A) Polarized microscopic images of H&E-stained renal sections from rats treated with 0.7 mg/kg NaOx, 6 hours (n = 5), 24 hours (n = 5), 3 days (n = 5), and 7 days (n = 3) after treatment. (B) Segment-specific immunostaining of collecting ducts (AQP2), proximal tubules (AQP1), connecting tubules (CALB1), and the TAL of Henle (THP) from the treated rats. Bottom panels show separate images in the same panel as necessary. Scale bars: 50 μm. (C–F) Lumen and tubule diameters of the indicated tubule segments. (G) Cell heights in the indicated tubule segments 6 hours after NaOx challenge. (H) Immunoblot of PKD-associated signaling pathways in kidney lysates. NT, no treatment. (I) Immunofluorescence microscopic images showing p-S6 (Ser235/236) and p-STAT3 (Tyr705) at the indicated time points after NaOx challenge. Scale bar: 50 μm. (J) Ki67 immunostaining. Scale bar: 50 μm. (K) Kidney sections costained with Ki67 and p–histone H3 (Ser10) and quantification of positive cells as a percentage of total cells. (L) Quantification of TUNEL+ cells as a percentage of total cells. (M) IHC for the macrophage marker CD68 in untreated WT rats (Control) and WT rats treated with NaOx at the indicated time points after NaOx administration. Cy/+ rat kidney was stained for comparison. Arrows point to CD68+ macrophages. Scale bar: 50 μm. Box-and-whisker plots represent 90% of the values, with the median displayed as a line in between the second and third quartiles and the mean shown with intersecting bars. All panels are representative of 3 experiments. Error bars represent the SD. *P < 0.05, **P < 0.01, ***P < 0.001, and ψP < 0.0001, by Mann-Whitney U test .

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts